Xu D - Search Results

1

Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multi-center Cohort Study.

Yu G, Zhang Y, Yu S, Yin Z, Weng G, Xu N, Du X, Lin D, Xiao J, Sun Z, Zhang H, Liang X, Guo Z, Zhao W, Dai M, Fan Z, Xuan L, Liu H, Xu D, Ye J, Jiang X, Shi P, Jin H, Liu Q. Yu G, et al. Among authors: xu n, xu d. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1332. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531539

2

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study.

Liu H, Xuan L, Lin R, Deng L, Fan Z, Nie D, Li X, Liang X, Xu D, Zhang Y, Xu N, Ye J, Jin H, Lin D, Ma L, Sun J, Huang F, Liu Q. Liu H, et al. Among authors: xu n, xu d. Leukemia. 2021 Jul;35(7):2054-2063. doi: 10.1038/s41375-020-01090-4. Epub 2020 Nov 17. Leukemia. 2021. PMID: 33204013

3

Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study.

Xu D, Yang Y, Yin Z, Tu S, Nie D, Li Y, Huang Z, Sun Q, Huang C, Nie X, Yao Z, Shi P, Zhang Y, Jiang X, Liu Q, Yu G. Xu D, et al. Blood Cancer J. 2023 Nov 13;13(1):168. doi: 10.1038/s41408-023-00941-4. Blood Cancer J. 2023. PMID: 37957175 Free PMC article. No abstract available.

4

[Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].

ZHANG Y, CHEN YK, FAN ZP, XU D, JIANG QL, SUN J, LIU QF. ZHANG Y, et al. Among authors: xu d. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Mar;31(3):438-42. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21421478 Chinese.

5

Is Imatinib Maintenance Required for Patients with Relapse Chronic Myeloid Leukemia Post-Transplantation Obtaining CMR? A Pilot Retrospective Investigation.

Jin H, Xiong Y, Sun J, Zhang Y, Huang F, Zhou H, Fan Z, Xu D, Wei Y, Dai M, Feng R, Liu Q. Jin H, et al. Among authors: xu d. PLoS One. 2013 Jun 18;8(6):e65981. doi: 10.1371/journal.pone.0065981. Print 2013. PLoS One. 2013. PMID: 23823695 Free PMC article.

6

[Comparison of clinical efficacy between HLA-mismatched related and HLA-matched unrelated donor hematopoietic stem cell transplantation for hematopoietic malignancies].

Yu S, Dai M, Sun J, Fan Z, Huang F, Zhang Y, Jiang Q, Zhou H, Xu D, Meng F, Liu Q. Yu S, et al. Among authors: xu d. Zhonghua Xue Ye Xue Za Zhi. 2014 Sep;35(9):826-30. doi: 10.3760/cma.j.issn.0253-2727.2014.09.009. Zhonghua Xue Ye Xue Za Zhi. 2014. PMID: 25246252 Chinese.

7

Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia.

Yu G, Chen F, Yin C, Liu Q, Sun J, Xuan L, Fan Z, Wang Q, Liu X, Jiang Q, Xu D. Yu G, et al. Among authors: xu d. Oncotarget. 2017 Oct 31;8(63):107022-107032. doi: 10.18632/oncotarget.22206. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291008 Free PMC article.

8

Low serum miR-223 expression predicts poor outcome in patients with acute myeloid leukemia.

Yu G, Yin Z, He H, Zheng Z, Chai Y, Xuan L, Lin R, Wang Q, Li J, Xu D. Yu G, et al. Among authors: xu d. J Clin Lab Anal. 2020 Mar;34(3):e23096. doi: 10.1002/jcla.23096. Epub 2019 Nov 6. J Clin Lab Anal. 2020. PMID: 31691380 Free PMC article.

9

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation.

Xu D, Chen Y, Yang Y, Yin Z, Huang C, Wang Q, Jiang L, Jiang X, Yin C, Liu Q, Yu G. Xu D, et al. J Transl Med. 2022 Jul 6;20(1):300. doi: 10.1186/s12967-022-03498-1. J Transl Med. 2022. PMID: 35794565 Free PMC article.

10

Changing epidemiology, microbiology and mortality of bloodstream infections in patients with haematological malignancies before and during SARS-CoV-2 pandemic: a retrospective cohort study.

Cai L, Chen H, Wei Y, Guo X, Zheng H, Jiang X, Zhang Y, Yu G, Dai M, Ye J, Zhou H, Xu D, Huang F, Fan Z, Xu N, Shi P, Xuan L, Feng R, Liu X, Sun J, Liu Q, Wei X. Cai L, et al. Among authors: xu n, xu d. BMJ Open. 2023 Dec 30;13(12):e078510. doi: 10.1136/bmjopen-2023-078510. BMJ Open. 2023. PMID: 38159939 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,733 results

Search Page

Filters